KAZAN (RU), November 2021 — Tay-Sachs disease is one of the orphan diseases currently focused on by many research groups worldwide.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
IRVINE, CA (US), November 2021 — More than four times as many businesses and clinics than were identified in 2016 are selling stem cell products not approved by the U.S.
BOSTON, MA (US), November 2021 — As we age, many of us acquire mutations that cause some of our blood stem cells to multiply faster than others, forming their own distinct populations or “clones.” This is known as clonal hematopoiesis.
JOHANNESBURG (SA), October 2021 — Stem cell therapy needs a lot of human cells of a specific type. Shining a near-infrared laser on adult stem cells derived from human body fat makes the stem cells replicate 54 percent faster.
KAZAN (RU), October 2021 — A gene-cell preparation by Kazan Federal University comprises a patient’s stem cells specifically modified to synthesize several therapeutic proteins.
BETHESDA, MD (US), October 2021 — As scientists move closer to testing regenerative therapies for eye disease, techniques are needed to monitor transplanted cells as they integrate with host tissues.
Philidelphia, PA (October 2021) - With age, the human heart gradually loses its ability to repair itself following injury.
BOSTON, MA (US), October 2021 — At the earliest stages of human embryonic development, a small collection of cells known as human embryonic stem cells (hESCs) orchestrates growth and differentiation, eventually giving rise to highly specialized human tissues.
CAMBRIDGE (UK), October 2021 — Cambridge researchers have developed “mini brains” that allow them to study a fatal and untreatable neurological disorder causing paralysis and dementia – and for the first time have been able to grow these for almost a year.
BIRMINGHAM, AL (US), October 2021 — A heart attack kills heart muscle cells, leading to a scar that weakens the heart, often leading to eventual heart failure.